ubmslateOT-logo-ubm

OT mobile menu

Search form

Topics:

News

News

The FDA on March 23, 2017, granted accelerated approval to avelumab (Bavencio) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma.

Quantitative morphological features of tumor pathological images may help predict prognosis in patients with non-small cell lung cancer.

Penn State College of Medicine researchers have discovered a new class of drugs that may keep a deadly form of skin cancer from becoming resistant to treatment.

A new population-based study is suggesting that there are significant racial disparities in gene expression profiling testing in women with breast cancer.

We spoke with Dr. G. Larry Maxwell, Chair of the Department of Obstetrics and Gynecology at Inova Fairfax Hospital, about a potential new biomarker to help distinguish metastatic versus nonmetastatic disease in endometrial cancer.

Researchers at the NYU Langone Medical Center’s Perlmutter Cancer Center have discovered multiple somatic mutations and copy-number alterations in UCS tumors that offer expanded therapeutic options.

Scientists from Dana-Farber Cancer Institute found that a compound that can reverse the function of innate immune system cells—to fight tumors rather than encourage growth—caused breast tumors in mice to shrink and withdraw from distant metastases.

Pages

Subscribe to News on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.